ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.667,83
0,85%
S&P 500
6.032,38
0,56%
US Dollar vs BRL
5,97435
0,00%
Bitcoin
96.524,82
-0,99%
Brent Oil
71,98
-0,08%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Roquefort Therapeutics Plc (ROQ)

  7. Roquefort Therapeutics Plc (ROQ) Notícias

ROQ

Roquefort Therapeutics (ROQ)

Roquefort Therapeutics Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:ROQ
DataHoraFonteTítuloCódigoCompanhia
07/11/202404:00RNS Regulatory NewsRoquefort Therapeutics PLC Conversion of Convertible Loan NotesLSE:ROQRoquefort Therapeutics Plc
06/11/202404:00RNS Non-RegulatoryRoquefort Therapeutics PLC STAT-6 siRNA PresentationLSE:ROQRoquefort Therapeutics Plc
27/09/202409:56Alliance NewsAlliance NewsEARNINGS: Kendrick Resources loss narrows; Emmerson CFO to departLSE:ROQRoquefort Therapeutics Plc
27/09/202403:00RNS Regulatory NewsRoquefort Therapeutics PLC Interim Results to 30 June 2024LSE:ROQRoquefort Therapeutics Plc
23/09/202413:51Alliance NewsAlliance NewsRoquefort Therapeutics says MK cell therapy patent approved in JapanLSE:ROQRoquefort Therapeutics Plc
23/09/202403:00RNS Regulatory NewsRoquefort Therapeutics PLC Grant of Japan MK Cell PatentLSE:ROQRoquefort Therapeutics Plc
19/09/202403:00RNS Regulatory NewsRoquefort Therapeutics PLC STAT-6 siRNA Demonstrates Efficacy in ImmunologyLSE:ROQRoquefort Therapeutics Plc
02/09/202403:00RNS Regulatory NewsRoquefort Therapeutics PLC Grant of MK Cell Patent & Licencing UpdateLSE:ROQRoquefort Therapeutics Plc
27/06/202408:46RNS Regulatory NewsRoquefort Therapeutics PLC Results of AGMLSE:ROQRoquefort Therapeutics Plc
20/06/202403:00RNS Regulatory NewsRoquefort Therapeutics PLC Appointment of BrokerLSE:ROQRoquefort Therapeutics Plc
04/06/202403:00RNS Regulatory NewsRoquefort Therapeutics PLC Notice of Annual General MeetingLSE:ROQRoquefort Therapeutics Plc
23/05/202417:25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:ROQRoquefort Therapeutics Plc
23/05/202403:05RNS Regulatory NewsRoquefort Therapeutics PLC Issue of Convertible Loan Notes & Board ChangesLSE:ROQRoquefort Therapeutics Plc
23/05/202403:00RNS Regulatory NewsRoquefort Therapeutics PLC Midkine Antibody Licencing DealLSE:ROQRoquefort Therapeutics Plc
26/04/202416:59Alliance NewsAlliance NewsEARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters GermanyLSE:ROQRoquefort Therapeutics Plc
26/04/202403:00RNS Regulatory NewsRoquefort Therapeutics PLC Annual Report & Financial Statements - 31 Dec 2023LSE:ROQRoquefort Therapeutics Plc
05/04/202408:32Alliance NewsAlliance NewsIN BRIEF: Roquefort cancels fundraise after "unusual" stock movementsLSE:ROQRoquefort Therapeutics Plc
05/04/202403:00RNS Regulatory NewsRoquefort Therapeutics PLC Response to Share Price MovementLSE:ROQRoquefort Therapeutics Plc
11/03/202408:12Alliance NewsAlliance NewsRoquefort celebrates "significant milestones" in cancer researchLSE:ROQRoquefort Therapeutics Plc
11/03/202404:00RNS Regulatory NewsRoquefort Therapeutics PLC Positive Results: Midkine mRNA and STAT-6 siRNALSE:ROQRoquefort Therapeutics Plc
06/02/202413:50Alliance NewsAlliance NewsIN BRIEF: Roquefort hails further MK studies, licence talks continueLSE:ROQRoquefort Therapeutics Plc
06/02/202404:00RNS Regulatory NewsRoquefort Therapeutics PLC Operations UpdateLSE:ROQRoquefort Therapeutics Plc
24/11/202304:00UK RegulatoryRoquefort Therapeutics PLC Change of AuditorLSE:ROQRoquefort Therapeutics Plc
06/11/202309:01Alliance NewsAlliance NewsRoquefort Therapeutics MK cell programme shows positive resultsLSE:ROQRoquefort Therapeutics Plc
06/11/202304:00UK RegulatoryRoquefort Therapeutics PLC Significant Mesodermal Killer Cell MilestoneLSE:ROQRoquefort Therapeutics Plc
27/09/202311:43Alliance NewsAlliance NewsEARNINGS: Biome loss widens; Amicorp focused on growth post-IPOLSE:ROQRoquefort Therapeutics Plc
27/09/202303:00UK RegulatoryRoquefort Therapeutics PLC Interim Results to 30 June 2023LSE:ROQRoquefort Therapeutics Plc
22/09/202307:42RNS Non-RegulatoryRoquefort Therapeutics PLC Investor Presentation via Investor Meet CompanyLSE:ROQRoquefort Therapeutics Plc
14/08/202307:07Alliance NewsAlliance NewsRoquefort files patent application for mRNA and RNA therapiesLSE:ROQRoquefort Therapeutics Plc
14/08/202303:00UK RegulatoryRoquefort Therapeutics PLC Expansion of Patent PortfolioLSE:ROQRoquefort Therapeutics Plc
 Apresentando as notícias mais relevantes sobre:LSE:ROQ

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
ATOM3
ATOMPAR ON
BOV
COGN3
COGNA ON
BOV
IDIV
Dividend
BOV
BRFS3
BRF S/A ON
BOV
AZEV4
AZEVEDO PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Economize até 50%* para TRADER BRASIL

1 ano 30%, 2 anos 40% e *3 anos 50%

*Ao longo de 3 anos $ 881.64 apenas $ 440.82